↓ Skip to main content

Tenofovir or zidovudine in three-drug combination therapy with one nucleoside reverse transcriptase inhibitor and one non-nucleoside reverse transcriptase inhibitor for initial treatment of HIV…

Overview of attention for article published in Cochrane database of systematic reviews, October 2010
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
32 Dimensions

Readers on

mendeley
162 Mendeley
connotea
1 Connotea
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Tenofovir or zidovudine in three-drug combination therapy with one nucleoside reverse transcriptase inhibitor and one non-nucleoside reverse transcriptase inhibitor for initial treatment of HIV infection in antiretroviral-naïve individuals
Published in
Cochrane database of systematic reviews, October 2010
DOI 10.1002/14651858.cd008740
Pubmed ID
Authors

Alicen Spaulding, George W Rutherford, Nandi Siegfried

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 162 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 1%
Ireland 1 <1%
Ethiopia 1 <1%
United Kingdom 1 <1%
Netherlands 1 <1%
Unknown 156 96%

Demographic breakdown

Readers by professional status Count As %
Student > Master 34 21%
Researcher 20 12%
Student > Bachelor 18 11%
Student > Ph. D. Student 16 10%
Other 15 9%
Other 33 20%
Unknown 26 16%
Readers by discipline Count As %
Medicine and Dentistry 74 46%
Social Sciences 12 7%
Nursing and Health Professions 11 7%
Agricultural and Biological Sciences 6 4%
Immunology and Microbiology 4 2%
Other 22 14%
Unknown 33 20%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 May 2021.
All research outputs
#12,858,707
of 19,461,063 outputs
Outputs from Cochrane database of systematic reviews
#10,333
of 11,935 outputs
Outputs of similar age
#199,243
of 344,152 outputs
Outputs of similar age from Cochrane database of systematic reviews
#29
of 29 outputs
Altmetric has tracked 19,461,063 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 11,935 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 27.5. This one is in the 9th percentile – i.e., 9% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 344,152 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 33rd percentile – i.e., 33% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 29 others from the same source and published within six weeks on either side of this one. This one is in the 3rd percentile – i.e., 3% of its contemporaries scored the same or lower than it.